IL1B and autoinflammation, panniculitis, and dermatosis syndrome, autosomal recessive: Thus, it seems interesting to evaluate those signaling pathways in ORAS patients in addition to TNF signaling in the future, although an anti-IL-1β agent was not effective in ORAS patients in general.